Nektar Therapeutics
NKTR
NKTR
144 hedge funds and large institutions have $1.48B invested in Nektar Therapeutics in 2014 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 56 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 138 → 144 (+6)
25% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 56
Holders
144
Holding in Top 10
2
Calls
$17.1M
Puts
$4.36M
Top Buyers
| 1 | +$12M | |
| 2 | +$10.2M | |
| 3 | +$6.26M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.76M |
| 5 |
Primecap Management
Pasadena,
California
|
+$3.46M |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$12.7M | |
| 3 | -$6.07M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.91M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.75M |